Resverlogix in Race to Make 'Good Cholesterol' Drug (Reuter


Reuters - Tiny Canadian biotech Resverlogix Corp.
is pitting itself against giants like Pfizer Inc. and Roche
Holding AG in a race to develop a "good" cholesterol drug that
holds the promise of a multi-billion dollar payoff at the
finish line.

Read more...